Patents by Inventor Sang-Nae Cho

Sang-Nae Cho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for preventing or treating tuberculosis
    Patent number: 9364468
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating tuberculosis, comprising: (a) a pharmaceutically effective amount of a compound represented by the following chemical formula 1; and (b) a pharmaceutically acceptable carrier. Chemical formula 1 The compound contained as an active ingredient of the present invention inhibits the expression and activity of CO-DH in tubercle bacillus so as to effectively block the detoxification of carbon monoxide, which is an important survival factor of tubercle bacillus, and is safe for the human body since the compound targets CO-DH which does not exist in the human body. In addition, the compound creates a synergistic effect when combined with a conventional tuberculostatic drug, and thus can be more effective for treating tuberculosis.
    Type: Grant
    Filed: February 13, 2013
    Date of Patent: June 14, 2016
    Assignee: INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
    Inventors: Young Min Kim, Seung Jung Han, Tae Gwon Oh, Sae Woong Park, Sang Nae Cho, Mi Young Hahn, Jee Hee Suh, Kyu Yang Yi
  • PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING TUBERCULOSIS
    Publication number: 20150133503
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating tuberculosis, comprising: (a) a pharmaceutically effective amount of a compound represented by the following chemical formula 1; and (b) a pharmaceutically acceptable carrier. Chemical formula 1 The compound contained as an active ingredient of the present invention inhibits the expression and activity of CO-DH in tubercle bacillus so as to effectively block the detoxification of carbon monoxide, which is an important survival factor of tubercle bacillus, and is safe for the human body since the compound targets CO-DH which does not exist in the human body. In addition, the compound creates a synergistic effect when combined with a conventional tuberculostatic drug, and thus can be more effective for treating tuberculosis.
    Type: Application
    Filed: February 13, 2013
    Publication date: May 14, 2015
    Inventors: Young Min Kim, Seung Jung Han, Tae Gwon Oh, Sae Woong Park, Sang Nae Cho, Mi Young Hahn, Jee Hee Suh, Kyu Yang Yi
  • PROBE FOR HPV GENOTYPE DIAGNOSIS AND ANALYSIS METHOD THEREOF
    Publication number: 20130078614
    Abstract: The present invention relates to a probe for diagnosing HPV genotype and to a method of analyzing the same.
    Type: Application
    Filed: February 12, 2010
    Publication date: March 28, 2013
    Applicants: Yonsei University Wonju Industry-Academic Cooperation Foundation, M & D, Inc.
    Inventors: Sang-Nae Cho, Tae-Woo Kim, Kwang-Hwa Park, Hye-Young Lee, Dong-Sup Lee, Mi-Ran Kang, Hye-Young Wang, Sung-hyun Kim
  • rpoB gene fragments and a method for the diagnosis and identification of Mycobacterium tuberculosis and non-tuberculosis Mycobacterial strains
    Patent number: 6951718
    Abstract: The present invention is related to rpoB gene fragments and method for the diagnosis and identification of Mycobacterium tuberculosis and non-lubercuolsis Mycobacterial strains using rpoB gene and it's fragments.
    Type: Grant
    Filed: October 27, 2000
    Date of Patent: October 4, 2005
    Inventors: Hyeyoung Lee, Young Kil Park, Gill-Han Bai, Sang-Jae Kim, Sang-Nae Cho, Yeun Kim, Hee Jung Park
  • METHOD FOR IDENTIFYING MYCOBACTERIUM TUBERCULOSIS AND MYCOBACTERIA OTHER THAN TUBERCULOSIS, TOGETHER WITH DETECTING RESISTANCE TO AN ANTITUBERCULOSIS DRUG OF MYCOBACTERIA OBTAINED BY MUTATION OF RPOB GENE
    Patent number: 6815165
    Abstract: The present invention provides a method for identifying Mycobacterium tuberculosis and non-tuberculosis Mycobacterium (MOTT), and for the determination of drug susceptibility of M. tuberculosis based on detection of mutations in the rpoB gene.
    Type: Grant
    Filed: January 30, 2002
    Date of Patent: November 9, 2004
    Inventors: Hyeyoung Lee, Hye Eun Bang, Sang-Nae Cho, Gill-Han Bai, Sang-Jae Kim
  • Method for identifying mycobacterium tuberculosis and mycobacteria other than tuberculosis, together with detecting resistance to an antituberculosis drug of mycobateria obtained by mutation of rpoB gene
    Publication number: 20030108881
    Abstract: The present invention provides a method for identifying Mycobacterium tuberculosis and non-tuberculosis Mycobacterium (MOTT), and for the determination of drug susceptibility of M. tuberculosis based on detection of mutations in the rpoB gene.
    Type: Application
    Filed: January 30, 2002
    Publication date: June 12, 2003
    Applicant: Xeniss Life Science Co., Ltd.
    Inventors: Hyeyoung Lee, Hye Eun Bang, Sang-Nae Cho, Gill-Han Bai, Sang-Jae Kim